244 related articles for article (PubMed ID: 30071261)
21. Characterization of mycosporine-like amino acids in the cyanobacterium Nostoc verrucosum.
Inoue-Sakamoto K; Nazifi E; Tsuji C; Asano T; Nishiuchi T; Matsugo S; Ishihara K; Kanesaki Y; Yoshikawa H; Sakamoto T
J Gen Appl Microbiol; 2018 Nov; 64(5):203-211. PubMed ID: 29709901
[TBL] [Abstract][Full Text] [Related]
22. Efficient production of mycosporine-like amino acids, natural sunscreens, in Yarrowia lipolytica.
Jin H; Kim S; Lee D; Ledesma-Amaro R; Hahn JS
Biotechnol Biofuels Bioprod; 2023 Oct; 16(1):162. PubMed ID: 37899467
[TBL] [Abstract][Full Text] [Related]
23. Photophysicochemical characterization of mycosporine-like amino acids in micellar solutions.
Orallo DE; Bertolotti SG; Churio MS
Photochem Photobiol Sci; 2017 Jul; 16(7):1117-1125. PubMed ID: 28548169
[TBL] [Abstract][Full Text] [Related]
24. Optimization of 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acids as inhibitors of Keap1-Nrf2 protein-protein interaction to suppress neuroinflammation.
Abed DA; Lee S; Wen X; Ali AR; Mangipudy V; Aleksunes LM; Hu L
Bioorg Med Chem; 2021 Aug; 44():116300. PubMed ID: 34252790
[TBL] [Abstract][Full Text] [Related]
25. The contribution of mycosporine-like amino acids, chromophoric dissolved organic matter and particles to the UV protection of sea-ice organisms in the Baltic Sea.
Piiparinen J; Enberg S; Rintala JM; Sommaruga R; Majaneva M; Autio R; Vähätalo AV
Photochem Photobiol Sci; 2015 May; 14(5):1025-38. PubMed ID: 25837523
[TBL] [Abstract][Full Text] [Related]
26. Glycosylated porphyra-334 and palythine-threonine from the terrestrial cyanobacterium Nostoc commune.
Nazifi E; Wada N; Yamaba M; Asano T; Nishiuchi T; Matsugo S; Sakamoto T
Mar Drugs; 2013 Aug; 11(9):3124-54. PubMed ID: 24065157
[TBL] [Abstract][Full Text] [Related]
27. The Keap1-Nrf2 protein-protein interaction: A suitable target for small molecules.
Schmoll D; Engel CK; Glombik H
Drug Discov Today Technol; 2017 Jun; 24():11-17. PubMed ID: 29233294
[TBL] [Abstract][Full Text] [Related]
28. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Collagenase by Mycosporine-like Amino Acids from Marine Sources.
Hartmann A; Gostner J; Fuchs JE; Chaita E; Aligiannis N; Skaltsounis L; Ganzera M
Planta Med; 2015 Jul; 81(10):813-20. PubMed ID: 26039265
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Mycosporine-Like Amino Acids in Selected Algae and Cyanobacteria by Hydrophilic Interaction Liquid Chromatography and a Novel MAA from the Red Alga Catenella repens.
Hartmann A; Becker K; Karsten U; Remias D; Ganzera M
Mar Drugs; 2015 Oct; 13(10):6291-305. PubMed ID: 26473886
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses.
Perez-Leal O; Barrero CA; Merali S
J Biol Chem; 2017 Aug; 292(34):14108-14121. PubMed ID: 28684421
[TBL] [Abstract][Full Text] [Related]
32. Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein-Protein Interaction.
Zhang Y; Shi Z; Zhou Y; Xiao Q; Wang H; Peng Y
J Med Chem; 2020 Aug; 63(15):7986-8002. PubMed ID: 32233486
[TBL] [Abstract][Full Text] [Related]
33. Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
Unni S; Deshmukh P; Krishnappa G; Kommu P; Padmanabhan B
FEBS J; 2021 Mar; 288(5):1599-1613. PubMed ID: 32672401
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil elastase inhibitor suppresses oxidative stress in obese asthmatic rats by activating Keap1/Nrf2 signaling pathway.
Zheng JQ; Zhang GR; Li J; Bi HW
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):361-369. PubMed ID: 30657578
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency.
Lu MC; Jiao Q; Liu T; Tan SJ; Zhou HS; You QD; Jiang ZY
Eur J Med Chem; 2018 Jan; 143():1578-1589. PubMed ID: 29117896
[TBL] [Abstract][Full Text] [Related]
36. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.
Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998
[TBL] [Abstract][Full Text] [Related]
37. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
Tocmo R; Parkin K
Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
[TBL] [Abstract][Full Text] [Related]
38. Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors.
Mou Y; Wen S; Li YX; Gao XX; Zhang X; Jiang ZY
Eur J Med Chem; 2020 Sep; 202():112532. PubMed ID: 32668381
[TBL] [Abstract][Full Text] [Related]
39. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
[TBL] [Abstract][Full Text] [Related]
40. DNA damage protecting and free radical scavenging properties of mycosporine-2-glycine from the Dead Sea cyanobacterium in A375 human melanoma cell lines.
Cheewinthamrongrod V; Kageyama H; Palaga T; Takabe T; Waditee-Sirisattha R
J Photochem Photobiol B; 2016 Nov; 164():289-295. PubMed ID: 27718421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
